Shiu-Lok Hu

4.2k total citations
71 papers, 3.2k citations indexed

About

Shiu-Lok Hu is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Shiu-Lok Hu has authored 71 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Virology, 27 papers in Immunology and 26 papers in Infectious Diseases. Recurrent topics in Shiu-Lok Hu's work include HIV Research and Treatment (62 papers), HIV/AIDS drug development and treatment (20 papers) and Immune Cell Function and Interaction (16 papers). Shiu-Lok Hu is often cited by papers focused on HIV Research and Treatment (62 papers), HIV/AIDS drug development and treatment (20 papers) and Immune Cell Function and Interaction (16 papers). Shiu-Lok Hu collaborates with scholars based in United States, Germany and Sweden. Shiu-Lok Hu's co-authors include Greg Brennan, Ingegerd Hellström, Bruce Travis, David C. Montefiori, Nancy L. Haigwood, Patricia Polacino, Andrew J. Watson, K. E. Hellström, Philip R. Johnson and Elaine K. Thomas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Shiu-Lok Hu

71 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shiu-Lok Hu United States	29	2.1k	1.5k	1.0k	896	889	71	3.2k
Kazuyasu Mori Japan	26	2.6k 1.3×	1.5k 1.1×	926 0.9×	506 0.6×	1.3k 1.4×	57	3.4k
Timothy W. Baba United States	21	2.4k 1.2×	1.5k 1.0×	1.0k 1.0×	676 0.8×	982 1.1×	33	3.2k
Guido Vanham Belgium	34	1.6k 0.8×	1.7k 1.2×	779 0.8×	946 1.1×	1.3k 1.5×	104	3.6k
Andrew I. Dayton United States	23	2.3k 1.1×	1.1k 0.7×	581 0.6×	1.5k 1.6×	1.4k 1.5×	39	3.6k
Nicoletta Casartelli France	23	1.8k 0.9×	1.9k 1.3×	840 0.8×	916 1.0×	1.2k 1.3×	39	3.6k
Kathelyn S. Steimer United States	29	2.2k 1.1×	1.4k 1.0×	772 0.7×	950 1.1×	1.1k 1.2×	53	3.4k
Massimo Pizzato Italy	28	1.7k 0.8×	1.0k 0.7×	733 0.7×	979 1.1×	953 1.1×	54	2.9k
Françoise Porrot France	26	1.5k 0.7×	1.5k 1.0×	575 0.6×	722 0.8×	1.1k 1.3×	46	3.1k
Michael S. Wyand United States	31	2.4k 1.2×	2.1k 1.4×	1.3k 1.2×	817 0.9×	969 1.1×	53	4.0k
Eva G. Rakasz United States	30	2.5k 1.2×	2.2k 1.5×	778 0.8×	637 0.7×	870 1.0×	102	3.6k

Countries citing papers authored by Shiu-Lok Hu

Since Specialization

Citations

This map shows the geographic impact of Shiu-Lok Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiu-Lok Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiu-Lok Hu more than expected).

Fields of papers citing papers by Shiu-Lok Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiu-Lok Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiu-Lok Hu. The network helps show where Shiu-Lok Hu may publish in the future.

Co-authorship network of co-authors of Shiu-Lok Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Shiu-Lok Hu. A scholar is included among the top collaborators of Shiu-Lok Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiu-Lok Hu. Shiu-Lok Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Ying, Shiu-Lok Hu, Jia‐Tsrong Jan, et al.. (2021). Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters. PLoS ONE. 16(9). e0257191–e0257191. 16 indexed citations

Peterson, Christopher W., Jianbin Wang, Claire Deléage, et al.. (2018). Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy. PLoS Pathogens. 14(4). e1006956–e1006956. 26 indexed citations

Feder, Alison F., Christopher E. Kline, Patricia Polacino, et al.. (2017). A spatio-temporal assessment of simian/human immunodeficiency virus (SHIV) evolution reveals a highly dynamic process within the host. PLoS Pathogens. 13(5). e1006358–e1006358. 17 indexed citations

Liang, Yu, Miklós Guttman, James A. Williams, et al.. (2016). Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan. Journal of Virology. 90(20). 9224–9236. 20 indexed citations

Lakhashe, Samir K., Nagadenahalli B. Siddappa, Shiu-Lok Hu, et al.. (2014). Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus. Vaccine. 32(48). 6527–6536. 4 indexed citations

Song, Kejing, Grace A. Maresh, Maria Cecilia Huaman, et al.. (2013). Expression of the Memory Marker CD45RO on Helper T Cells in Macaques. PLoS ONE. 8(9). e73969–e73969. 8 indexed citations

Dietrich, Elizabeth A., Lisa Jones‐Engel, & Shiu-Lok Hu. (2010). Evolution of the Antiretroviral Restriction Factor TRIMCyp in Old World Primates. PLoS ONE. 5(11). e14019–e14019. 18 indexed citations

Gruber, Andreas, Robert A. Rasmussen, Helena Ong, et al.. (2007). Dendritic Cell-Based Vaccine Strategy against Human Immunodeficiency Virus Clade C: Skewing The Immune Response Toward A Helper T Cell Type 2 Profile. Viral Immunology. 20(1). 160–169. 15 indexed citations

Rasmussen, Robert A., Helena Ong, Ruijiang Song, et al.. (2007). Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges. AIDS. 21(14). 1841–1848. 19 indexed citations

10.

Mossman, Sally, Andrew J. Watson, Michael Robertson, et al.. (2004). Protective Immunity to SIV Challenge Elicited by Vaccination of Macaques with Multigenic DNA Vaccines Producing Virus-Like Particles. AIDS Research and Human Retroviruses. 20(4). 425–434. 19 indexed citations

11.

Zhu, Tuofu, Shiu-Lok Hu, Feng Feng, et al.. (2004). Persistence of low levels of simian immunodeficiency virus in macaques that were transiently viremic by conventional testing. Virology. 323(2). 208–219. 11 indexed citations

12.

Ambrose, Zandrea, Kay Larsen, LaRene Kuller, et al.. (2003). Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV89.6. Virology. 308(1). 178–190. 3 indexed citations

13.

Eitner, Frank, Yan Cui, Kelly L. Hudkins, et al.. (1999). Thrombotic Microangiopathy in the HIV-2-Infected Macaque. American Journal Of Pathology. 155(2). 649–661. 22 indexed citations

14.

Robinson, Harriet L., David C. Montefiori, R. Paul Johnson, et al.. (1999). Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nature Medicine. 5(5). 526–534. 316 indexed citations

15.

Lu, Shan, et al.. (1998). Studies of the Neutralizing Activity and Avidity of Anti-Human Immunodeficiency Virus Type 1 Env Antibody Elicited by DNA Priming and Protein Boosting. Journal of Virology. 72(11). 9092–9100. 105 indexed citations

16.

Heidecker, Gisela, Patricia A. Lloyd, David R. Hodge, et al.. (1998). Sequence diversity of SIV_Mne Nef in vivo and in vitro. Journal of Medical Primatology. 27(2-3). 73–80. 1 indexed citations

17.

Heidecker, Gisela, Patricia A. Lloyd, David R. Hodge, et al.. (1998). Macaques Infected with Cloned Simian Immunodeficiency Virus Show RecurringnefGene Alterations. Virology. 249(2). 260–274. 12 indexed citations

18.

Graham, Barney S., Geoffrey J. Gorse, David H. Schwartz, et al.. (1994). Determinants Of Antibody Response After Recombinant Gp160 Boosting In Vaccinia-Naive Volunteers Primed With Gp160-Recombinant Vaccinia Virus. The Journal of Infectious Diseases. 170(4). 782–786. 29 indexed citations

19.

Cooney, Elizabeth, M J McElrath, Lawrence Corey, et al.. (1993). Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.. Proceedings of the National Academy of Sciences. 90(5). 1882–1886. 148 indexed citations

20.

Hu, Shiu-Lok, Bruce Travis, Virginia Stallard, et al.. (1992). Immune Responses to SIV mne Envelope Glycoproteins Protect Macaques from Homologous SIV Infection. AIDS Research and Human Retroviruses. 8(8). 1489–1494. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact